Wednesday, July 8, 2026

pharma · Polycythemia Vera · Ulcerative Colitis Chronic Moderate · PTGX

Protagonist Therapeutics

Protagonist Therapeutics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.

7707 Gateway Blvd, Suite 140, Newark, California 94560, US HQ
2006 Founded
153 Employees
Public company Type
PTGX · NYSE Ticker
Company details
Status
Public
HQ
7707 Gateway Blvd, Suite 140, Newark, California 94560, US
Founded
2006
Employees
153
Programs
13
Drugs
5
Patents
33
Intelligence · Clinical Trials

Protagonist Therapeutics clinical trials

Registry index of 15 ClinicalTrials.gov studies linked to Protagonist Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Protagonist Therapeutics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Protagonist Therapeutics.

  1. VERIFY — Phase 3

    Clinical update
  2. PN-881 Oral Solution — Phase 1

    Clinical update
  3. Placebo — Phase 3

    Clinical update
  4. Open-label rusfertide — Phase 3

    Clinical update
  5. PN-943 — Phase 2

    Clinical update
  6. PTG-100 — Phase 2

    Clinical update
  7. PTG-300 — Phase 2

    Clinical update
  8. PTG-300 — Phase 2

    Clinical update

Trial registry

15 studies